Searched for
PHARMACEUTICAL SECTOR
Military hardware, energy supply chains to fortify India-Japan tiesIndia and Japan have officially strengthened their strategic partnership, emphasizing initiatives aimed at economic security and collaborat...- For low risk-takers: 5 large-caps from different sectors with an upside potential of up to 31%Now, there is nothing wrong with being bullish, because it has always paid to be bullish. Yes, one might argue that it has not paid in the ...
- India-Japan Annual Summit to focus on AI, chips & clean energyThe two countries have identified semiconductors, critical minerals, pharmaceuticals, clean energy, and information and communication techn...
- Sensex rises over 150 points, Nifty above 23,900 as investors weigh Iran tensions, weak monsoon concernsIndian stock markets opened the second half of 2026 with modest gains after recent declines. Investors are closely watching escalating US-I...
- Duty waiver on petrochemical products extended till July 15Indian manufacturers will continue to benefit from a full customs duty exemption on imported petrochemicals until July 15. This extension a...
- India's manufacturing growth slows in Q1 as West Asia conflict weighs: FICCIIndia's manufacturing sector anticipates a slower growth phase in the April-June quarter of FY27, influenced by the West Asia conflict. Whi...
- India's underperformance sets stage for recovery, says JM Financial's Deepak GuptaIndian equities are showing signs of a potential rebound, with attractive valuations and improved currency stability, according to Deepak G...
- Govt extends customs duty waiver on import of key petrochemical products till July 15The government has extended the nil customs duty on approximately 40 critical petrochemical products by another 15 days, now until July 15....
- Manufacturing growth seen moderating in Q1 as West Asia crisis weighs on sentiment: FICCIIndia's manufacturing sector anticipates a slowdown in April-June FY27, influenced by West Asia tensions impacting business confidence. Des...
- Centre extends duty relief on key petrochemical products till July 15The government has extended the import duty exemption on about 40 key petrochemical products by 15 days, now until July 15. This move aims ...
- Delayed monsoon may weigh on auto demand, but long-term outlook stays strong: Aditya ShahA delayed monsoon poses a temporary challenge to rural auto demand, particularly for tractors and two-wheelers, but the sector's long-term ...
- India’s nutraceutical market set to nearly double to $57 billion by 2030 on preventive health boomIndia's health-conscious population is fueling a boom in the nutraceutical market, projected to nearly double to $55-57 billion by 2030. Th...
- Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
- Shelf-life norms for imported drugs may be relaxed to reduce wastageIndia is set to revise rules for imported medicines, proposing a 12-month minimum residual shelf life instead of the current 60% rule. This...
- WHO seeks details from India over oxytocin-linked deaths; licences of manufacturer cancelledThe World Health Organisation (WHO) has sought details from the Indian government after reports linked oxytocin injections made by Jackson ...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...
- India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- API prices fall as West Asia tensions ease, boosting Indian pharma sectorPrices for active pharmaceutical ingredients have seen a decline of five to ten percent, thanks to the calming geopolitical climate in West...
Load More
